phospho-CXCR4 (Ser339)抗体特异性结合抗原：抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞，通常需要补体或吞噬细胞等共同发挥效应以**病原微生物或导致病理损伤。然而，抗体可通过与病毒或**的特异性结合，直接发挥中和病毒的作用。
产物编号xy- 12256R
英文名称phospho-CXCR4 (Ser339)
中文名称磷酸化细胞表面趋化因子受体4抗体
别 名p-CXCR4 (phospho S339); p-CD184 (phospho S339); C-X-C chemokine receptor type 4; CXC-R4; CXCR-4; Stromal cell-derived factor 1 receptor; SDF-1 receptor; Fusin; Leukocyte-derived seven transmembrane domain receptor; LESTR; CD184 antigen; CXCR4_HUMAN.
说 明 书100ul
产物类型磷酸化抗体
研究领域肿瘤 细胞生物 **学 神经生物学 干细胞 生长因子和** 新陈代谢
抗体来源搁补产产颈迟
克隆类型笔辞濒测肠濒辞苍补濒
phospho-CXCR4 (Ser339)抗体交叉反应 Human, Mouse, Rat, Dog, Cow, Horse, Rabbit,
产物应用WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 Flow-Cyt=1μg/Test ICC=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量40kDa
细胞定位细胞膜
性 状Lyophilized or Liquid
浓 度1mg/1ml
免 疫 原KLH conjugated Synthesised phosphopeptide derived from human CXCR4 around the phosphorylation site of Ser339 [HS(p-S)VS]:HS(p-S)VS
亚 型IgG
纯化方法affinity purified by Protein A
储 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
phospho-CXCR4 (Ser339)抗体保存条件Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
PubMedPubMed
产物介绍产补肠办驳谤辞耻苍诲:
This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. Monomer. Can form dimers.
Function:
Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ions levels and enhancing MAPK1/MAPK3 activation. Acts as a receptor for extracellular ubiquitin; leading to enhance intracellular calcium ions and reduce cellular cAMP levels. Involved in haematopoiesis and in cardiac ventricular septum formation. Plays also an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Could be involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival. Acts as a coreceptor (CD4 being the primary receptor) for HIV-1 X4 isolates and as a primary receptor for some HIV-2 isolates. Promotes Env-mediated fusion of the virus.
Subunit:
Monomer. Can form dimmers.
Subcellular Location:
Cell membrane; Multi-pass membrane protein.
Tissue Specificity:
Expressed in numerous tissues, such as peripheral blood leukocytes, spleen, thymus, spinal cord, heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, cerebellum, cerebral cortex and medulla (in microglia as well as in astrocytes), brain microvascular, coronary artery and umbilical cord endothelial cells. Isoform 1 is predominant in all tissues tested.
Post-translational modifications:
Phosphorylated on agonist stimulation. Rapidly phosphorylated on serine and threonine residues in the C-terminal. Phosphorylation at Ser-324 and Ser-325 leads to recruitment of ITCH, ubiquitination and protein degradation.
Ubiquitinated by ITCH at the cell membrane on agonist stimulation. The ubiquitin-dependent mechanism, endosomal sorting complex required for transport (ESCRT), then targets CXCR4 for lysosomal degradation. This process is dependent also on prior Ser-/Thr-phosphorylation in the C-terminal of CXCR4. Also binding of ARRB1 to STAM negatively regulates CXCR4 sorting to lysosomes though modulating ubiquitination of SFR5S. Sulfation on Tyr-21 is required for efficient binding of CXCL12/SDF-1alpha and promotes its dimerization.
O- and N-glycosylated. Asn-11 is the principal site of N-glycosylation. There appears to be very little or no glycosylation on Asn-176. N-glycosylation masks coreceptor function in both X4 and R5 laboratory-adapted and primary HIV-1 strains through inhibiting interaction with their Env glycoproteins. The O-glycosylation chondroitin sulfate attachment does not affect interaction with CXCL12/SDF-1alpha nor its coreceptor activity.
DISEASE:
Defects in CXCR4 are a cause of WHIM syndrome (WHIM) [MIM:193670]; also known as warts, hypogammaglobulinemia, infections and myelokathexis. WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis.
Similarity:
Belongs to the G-protein coupled receptor 1 family.
SWISS:
P61073
Gene ID:
7852
phospho-CXCR4 (Ser339)抗体（antibody,
Ab）是由效应B细胞（效应**B细胞）分泌，机体用于抵御外来物质，如病毒，**等抗原，结构呈“驰”字型的球状蛋白质，仅仅存在于脊椎动物的血液和B**细胞膜表面。凡是能够跟抗体结合的物质，均被称作抗原，因此对于抗抗体（能够结合抗体的抗体）来说，抗体本身也是一种抗原物质。
phospho-CXCR4 (Ser339)抗体普通抗体重链和轻链的结构
重链结构：普通的**球蛋白具有2条重链（H链），分子量约为50kD,有μ、δ、γ、ε和α五种重链亚型，对应的**球蛋白名称分别为IgM、IgG、IgA、IgD和IgE。
轻链结构： 普通**球蛋白具有2条轻链（L链），分子质量约25kDa，有κ链和λ链两种亚型，这两种轻链决定了Ig的亚型类别（IgG1，IgG2，IgG3，IgG4）。一个天然的Ig分子两条轻链总是相同的，但在同一个体内可存在分别带有κ或λ链的抗体分子。不同种属生物体内两型轻链的比例不同，正常人血清**球蛋白κ链：λ链约为2：1，而在小鼠的比例为20：1。
2.2抗体Fab段和Fc段
滨驳骋经木瓜蛋白酶酶切后裂解为2个完全相同的Fab段和1个Fc段,每个Fab段都为单价,可与抗原结合但不会再发生凝集反应；经胃蛋白酶酶切后裂解为1个完整F(ab)2片段和碎片化的Fc片段,F(ab’)2片段为双价,可同时结合两个抗原表位。Fab段为抗原结合片段（fragment of antigen binding，Fab），相当于抗体分子的两个臂，由一个完整的轻链和重链的VH和CH1结构域组成。Fc段为可结晶段（fragment crystallizable，Fc）相当于Ig的CH2和CH3结构域，是Ig与效应分子或者细胞相互作用的部位。Fab段包含完整的可变区，以及恒定区的CH1区域。Fc段仅指Ig恒定区CH2和CH3的区域，相当于Y字结构下面那一部分。
合格 VPREB1 B**细胞前体蛋白1抗体
合格 GABRA1/GABA A Receptor alpha 1 G1氨基丁酸A型受体α1抗体
合格 合格 HFE 遗传性血色病蛋白相关蛋白1抗体
合格 合格 CPA3 肥大细胞羧肽酶A3抗体
合格 ETV2 ETS相关蛋白71抗体
合格 FLVCR 白血病病毒C亚类受体蛋白FLVCR抗体
合格 HES7 转录因子HES7抗体
合格 合格 CHI3L2 软骨细胞蛋白39抗体
合格 Hyaluronidase-1 透明质酸酶/玻璃酸酶抗体
合格 TAZ 转录共激活因子TAZ抗体
合格 FAM20C 胞外分泌型丝氨酸/苏氨酸蛋白激酶FAM20C抗体
合格 KIF13B 驱动蛋白家族蛋白13B抗体
合格 KIF7 驱动蛋白家族蛋白7抗体
合格 RAB23 G蛋白偶联受体RAB23抗体
合格 NLE1 NLE1蛋白抗体
合格 MAPK6 丝裂原活化蛋白激酶6抗体
合格 合格 SH3PX1 分选连接蛋白9抗体
合格 合格 human Fibrinogen 人纤维蛋白原抗体
合格 SNX6 分选连接蛋白6抗体
合格 合格 AMHR2 缪勒**2型受体抗体
合格 Activin receptor type-1 激活素受体1A抗体
合格 合格 合格 14-3-3 Tau 14-3-3τ蛋白抗体
合格 14-3-3 gamma 14-3-3γ抗体
合格 合格 14-3-3 sigma/MKRN3 14-3-3σ抗体
合格 CAPRIN2 胃癌多药耐药相关蛋白
合格 DOCK2 细胞质分裂付出蛋白2抗体
合格 Inversin 内脏器官发育转位相关蛋白NPH2抗体
合格 TPM2 原肌球蛋白抗体
合格 Cytokeratin 1 细胞角蛋白1抗体
合格 PLEKHG5 凋亡诱导受体PLEKHG5抗体
合格 ALDH9A1 γ-氨基丁酸醛脱氢酶抗体
合格 AMBN 釉基质蛋白抗体
合格 phospho-Androgen Receptor (Ser515) 磷酸化雄**受体抗体
合格 phospho-Androgen Receptor (Ser94) 磷酸化雄**受体抗体
合格 Annexin A13 膜粘连蛋白13抗体